newsfilter
← Latest News
Business Wire·

Vistagen to Present at the 2025 Anxiety and Depression Association Conference

Posters Highlight New Insights into Social Anxiety Disorder Vistagen (NASDAQ:VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a